Rishi Puri

Rishi Puri, MD, PhD, FRACP, is a coronary and structural interventional cardiologist at the Cleveland Clinic. He is also an Associate Professor of Medicine and Medical Director of the angiography and IVUS Core Laboratory. He completed his clinical and academic training in Adelaide (Sth Australia), Cleveland (USA), Quebec City (Canada), Rennes (France), and Zurich (Switzerland). Rishi has published over 400 original manuscripts in high-impact journals across a broad topic base including transcatheter structural heart interventions for valvular heart disease and heart failure, atherosclerosis progression-regression and plaque imaging, and coronary physiology/pharmacology. He is actively involved in developing novel device technologies in the coronary, structural heart disease and interventional heart failure spaces, has co-founded and advises a range of medical start-up companies. He currently serves as global co-PI for the soon-to-commence TRICAV FDA pivotal trial testing a bi-caval stenting system for patients with severe TR, the ADVANCE-DCB FIM trial of a dual API nanoparticle drug-eluting balloon in de novo coronary lesions, and is on the global steering committees of a range of pivotal trials in the aortic and mitral valve therapy space. Rishi is an Australian native, and enjoys his spare time traveling, road cycling, trail running and XC skiing.